Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. (KOSE:A002390) from Hoechst GmbH on September 26, 2012. Young-Jin Kim will acquire 0.696 million shares representing 6% stake in Handok Pharmaceuticals Co., Ltd. as a result of which his stake increases to 14.12%. Paean, Inc. will acquire approximately 3.48 million shares representing 29.99% stake in Handok Pharmaceuticals.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,530 KRW | -1.49% | -4.53% | +1.61% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.61% | 147M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- A002390 Stock
- News HANDOK Inc.
- Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. from Hoechst GmbH.